GKIM
SILK

GW&K Investment Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

GW&K Investment Management’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-176,293
Closed -$5.73M – 942
2023
Q2 		$5.73M Buy
176,293
+6,200
+4% +$226K 0.05% 262
2023
Q1 		$6.66M Buy
170,093
+22,432
+15% +$1.1M 0.06% 247
2022
Q4 		$7.8M Buy
147,661
+84,781
+135% +$4.13M 0.08% 230
2022
Q3 		$2.83M Sell
62,880
-3,050
-5% -$131K 0.03% 283
2022
Q2 		$2.4M Sell
65,930
-3,050
-4% -$111K 0.03% 293
2022
Q1 		$2.85M Sell
68,980
-1,490
-2% -$52.4K 0.03% 295
2021
Q4 		$3M Sell
70,470
-3,570
-5% -$179K 0.03% 301
2021
Q3 		$4.07M Buy
74,040
+210
+0.3% +$11K 0.04% 283
2021
Q2 		$3.53M Hold
73,830
– – 0.03% 303
2021
Q1 		$3.74M Sell
73,830
-1,205
-2% -$67K 0.03% 307
2020
Q4 		$4.73M Sell
75,035
-3,400
-4% -$211K 0.05% 267
2020
Q3 		$5.27M Buy
78,435
+115
+0.1% +$6.28K 0.07% 238
2020
Q2 		$3.28M Buy
+78,320
New +$3.01M 0.05% 257

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

GW&K Investment Management's SILK Position: Q3 2023 in Review

GW&K Investment Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 176,293 shares — an estimated $5.73M sold.

GW&K Investment Management first reported a position in SILK in Q2 2020 and held it in 13 quarters. The position peaked at $7.8M in Q4 2022. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

  • GW&K Investment Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • GW&K Investment Management sold 176,293 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $5.73M.
  • GW&K Investment Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 13 quarters.
  • GW&K Investment Management's Silk Road Medical, Inc. Common Stock position peaked at $7.8M in Q4 2022.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on GW&K Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.